U.S. flag

An official website of the United States government

Format
Items per page

Send to:

Choose Destination

Search results

Items: 1 to 20 of 657

1.

Basal cell carcinoma, susceptibility to, 7

Any skin basal cell carcinoma in which the cause of the disease is a mutation in the TP53 gene. [from MONDO]

MedGen UID:
766520
Concept ID:
C3553606
Finding
2.

Spinocerebellar ataxia 7

Spinocerebellar ataxia type 7 (SCA7) comprises a phenotypic spectrum ranging from adolescent- or adult-onset progressive cerebellar ataxia and cone-rod retinal dystrophy to infantile or early-childhood onset with multiorgan failure, an accelerated course, and early death. Anticipation in this nucleotide repeat disorder may be so dramatic that within a family a child with infantile or early-childhood onset may be diagnosed with what is thought to be an unrelated neurodegenerative disorder years before a parent or grandparent with a CAG repeat expansion becomes symptomatic. In adolescent-onset SCA7, the initial manifestation is typically impaired vision, followed by cerebellar ataxia. In those with adult onset, progressive cerebellar ataxia usually precedes the onset of visual manifestations. While the rate of progression varies in these two age groups, the eventual result for almost all affected individuals is loss of vision, severe dysarthria and dysphagia, and a bedridden state with loss of motor control. [from GeneReviews]

MedGen UID:
156006
Concept ID:
C0752125
Disease or Syndrome
3.

Microvascular complications of diabetes, susceptibility to, 7

Any microvascular complications of diabetes, susceptibility in which the cause of the disease is a mutation in the HFE gene. [from MONDO]

MedGen UID:
382123
Concept ID:
C2673520
Finding
4.

Epilepsy, idiopathic generalized, susceptibility to, 7

MedGen UID:
442800
Concept ID:
C2751729
Finding
5.

Hereditary spastic paraplegia 7

Spastic paraplegia 7 (SPG7) is characterized by insidiously progressive bilateral leg weakness and spasticity. Most affected individuals have decreased vibration sense and cerebellar signs. Onset is mostly in adulthood, although symptoms may start as early as age 11 years and as late as age 72 years. Additional features including ataxia (gait and limbs), spastic dysarthria, dysphagia, pale optic disks, ataxia, nystagmus, strabismus, ptosis, hearing loss, motor and sensory neuropathy, amyotrophy, scoliosis, pes cavus, and urinary sphincter disturbances may be observed. [from GeneReviews]

MedGen UID:
339552
Concept ID:
C1846564
Disease or Syndrome
6.

NPHP3-related Meckel-like syndrome

This autosomal recessive disorder is designated Meckel syndrome type 7 (MKS7) based on the classic phenotypic triad of (1) cystic renal disease; (2) a central nervous system abnormality, and (3) hepatic abnormalities, as defined by Meckel (1822), Salonen (1984), and Logan et al. (2011). According to these criteria, polydactyly is a variable feature. Herriot et al. (1991) and Al-Gazali et al. (1996) concluded that Dandy-Walker malformation can be the phenotypic manifestation of a central nervous system malformation in MKS. For a general phenotypic description and a discussion of genetic heterogeneity of Meckel syndrome, see MKS1 (249000). [from OMIM]

MedGen UID:
382217
Concept ID:
C2673885
Disease or Syndrome
7.

Psoriasis 7, susceptibility to

MedGen UID:
343057
Concept ID:
C1854124
Finding
8.

Glycogen storage disease, type VII

Glycogen storage disease VII is an autosomal recessive metabolic disorder characterized clinically by exercise intolerance, muscle cramping, exertional myopathy, and compensated hemolysis. Myoglobinuria may also occur. The deficiency of the muscle isoform of PFK results in a total and partial loss of muscle and red cell PFK activity, respectively. Raben and Sherman (1995) noted that not all patients with GSD VII seek medical care because in some cases it is a relatively mild disorder. [from OMIM]

MedGen UID:
5342
Concept ID:
C0017926
Disease or Syndrome
9.

SKIN/HAIR/EYE PIGMENTATION 7, DARK/LIGHT SKIN

MedGen UID:
436081
Concept ID:
C2674081
Finding
10.

Mucopolysaccharidosis type 7

Mucopolysaccharidosis type VII (MPS7) is an autosomal recessive lysosomal storage disease characterized by the inability to degrade glucuronic acid-containing glycosaminoglycans. The phenotype is highly variable, ranging from severe lethal hydrops fetalis to mild forms with survival into adulthood. Most patients with the intermediate phenotype show hepatomegaly, skeletal anomalies, coarse facies, and variable degrees of mental impairment (Shipley et al., 1993). MPS VII was the first autosomal mucopolysaccharidosis for which chromosomal assignment was achieved. [from OMIM]

MedGen UID:
43108
Concept ID:
C0085132
Disease or Syndrome
11.

Chromosome 7, monosomy

A chromosomal abnormality consisting of the absence of one of the copies of chromosome 7 in somatic cells. [from NCI]

MedGen UID:
307798
Concept ID:
C1513483
Cell or Molecular Dysfunction
12.

Andersen Tawil syndrome

Andersen-Tawil syndrome (ATS) is characterized by a triad of: episodic flaccid muscle weakness (i.e., periodic paralysis); ventricular arrhythmias and prolonged QT interval; and anomalies including low-set ears, widely spaced eyes, small mandible, fifth-digit clinodactyly, syndactyly, short stature, and scoliosis. Affected individuals present in the first or second decade with either cardiac symptoms (palpitations and/or syncope) or weakness that occurs spontaneously following prolonged rest or following rest after exertion. Mild permanent weakness is common. Mild learning difficulties and a distinct neurocognitive phenotype (i.e., deficits in executive function and abstract reasoning) have been described. [from GeneReviews]

MedGen UID:
327586
Concept ID:
C1563715
Disease or Syndrome
13.

Chromosome 7, monosomy 7q3

MedGen UID:
419121
Concept ID:
C2931625
Cell or Molecular Dysfunction
14.

Holoprosencephaly 7

Holoprosencephaly (HPE) is the most commonly occurring congenital structural forebrain anomaly in humans. HPE is associated with mental retardation and craniofacial malformations. Considerable heterogeneity in the genetic causes of HPE has been demonstrated (Ming et al., 2002). For general phenotypic information and a discussion of genetic heterogeneity of holoprosencephaly, see HPE1 (236100). [from OMIM]

MedGen UID:
372134
Concept ID:
C1835820
Disease or Syndrome
15.

Chromosome 7, monosomy 7q2

MedGen UID:
444103
Concept ID:
C2931623
Cell or Molecular Dysfunction
16.

Chromosome 7, monosomy 7q21

MedGen UID:
419455
Concept ID:
C2931624
Cell or Molecular Dysfunction
17.

Retinitis pigmentosa 7

A retinitis pigmentosa that has material basis in mutation in the PRPH2 gene on chromosome 6p21. [from MONDO]

MedGen UID:
334168
Concept ID:
C1842475
Disease or Syndrome
18.

Hypogonadotropic hypogonadism 7 with or without anosmia

Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is characterized by inappropriately low serum concentrations of the gonadotropins LH (luteinizing hormone) and FSH (follicle-stimulating hormone) in the presence of low circulating concentrations of sex steroids. IGD is associated with a normal sense of smell (normosmic IGD) in approximately 40% of affected individuals and an impaired sense of smell (Kallmann syndrome) in approximately 60%. IGD can first become apparent in infancy, adolescence, or adulthood. Infant boys with congenital IGD often have micropenis and cryptorchidism. Adolescents and adults with IGD have clinical evidence of hypogonadism and incomplete sexual maturation on physical examination. Adult males with IGD tend to have prepubertal testicular volume (i.e., <4 mL), absence of secondary sexual features (e.g., facial and axillary hair growth, deepening of the voice), decreased muscle mass, diminished libido, erectile dysfunction, and infertility. Adult females have little or no breast development and primary amenorrhea. Although skeletal maturation is delayed, the rate of linear growth is usually normal except for the absence of a distinct pubertal growth spurt. [from GeneReviews]

MedGen UID:
87440
Concept ID:
C0342384
Disease or Syndrome
19.

Partial duplication of chromosome 7

MedGen UID:
1383136
Concept ID:
C4518496
Cell or Molecular Dysfunction
20.

Partial deletion of chromosome 7

MedGen UID:
1825962
Concept ID:
C5679655
Cell or Molecular Dysfunction
Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Search details

See more...